Showing results (111-120 of 269) with videos related to
Sort By:
Pageof 27
Endocrinology|December 1, 1975
Interaction of spironolactone and digitalis with the 5 alpha-dihydrotestosterone (DHT) receptor of rat ventral prostateJ C Pita, M E Lippman, E B Thompson, et al.American Journal of Clinical Oncology|February 1, 1987
Adjuvant chemotherapy in males with cancer of the breastC S Bagley, M N Wesley, R C Young, et al.Endocrinology|January 1, 1986
Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cellsR B Dickson, K K Huff, E M Spencer, et al.Cancer Research|February 15, 1993
The role of cathepsin D in the invasiveness of human breast cancer cellsM D Johnson, J A Torri, M E Lippman, et al.Human Reproduction (Oxford, England)|June 1, 1994
Progestins and antiprogestins in mammary tumour growth and metastasisY E Shi, Y E Liu, M E Lippman, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1975
Competitive protein binding assay for methotrexateC E Myers, M E Lippman, H M Elliot, et al.West African Journal of Medicine|July 1, 1990
Progesterone receptors in advanced breast cancerL C Chiedozi, K K Huff, M E Wesley, et al.Clinical Endocrinology|August 1, 1983
Androgen receptor characteristics in skin fibroblasts from men with pubertal macromastiaC Eil, M E Lippman, E V De Moss, et al.Cancer Research|January 15, 1994
MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligandsS W McLeskey, I Y Ding, M E Lippman, et al.Annals of Internal Medicine|February 1, 1983
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancerD C Tormey, M E Lippman, B K Edwards, et al.Pageof 27